Cite
HARVARD Citation
Hirose, H. et al. (2017). Discovery of novel 5-oxa-2, 6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus. Bioorganic & medicinal chemistry. 25 (15), pp. 4175-4193. [Online].